Skip to Content

Clinical Trials Search Results

Showing 1-2 of 2

Sorted By:

  • BMS 143

    An Expanded Access Program for Elotuzumab in Combination with Lenalidomide plus Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

  • SWOG S1304

    A Phrase II randomized study comparing Two doses of Carfilzomib (NSC-756640) with Dexamethasone for Multiple Myeloma patients with Relapsed or Refractory disease

Showing trials 1-2 of 2

Also in this Section